Merck’s (MRK) Keytruda QLEX approved in Japan for subcutaneous administration for all Keytruda indications approved in Japan

Newsquawk StaffPublished On the live feed at 6 more headlines followed before this page went public
Newsquawk headlinesUTC

Fed's Goolsbee (2027 voter) says the Fed must have courage to fight inflation

Yemeni Houthi official warns Egypt, Turkey and Pakistan will likely be targeted in the next stages

Merck’s (MRK) Keytruda QLEX approved in Japan for subcutaneous administration for all Keytruda indications approved in Japan

Micron's (MU) Taoyuan Union says it plans to hold strike vote after mediation ended without agreement; company did not offer concrete profit-sharing proposal at mediation

Pakistan Interior Minister has arrived in Tehran, IRNA reports

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Free. No signup, no card.

Related headlines

The whole workspace, free to try.

Try it free